Igm Monoclonal Gammopathy of Undetermined Significance
📧 Sign up to get email alerts when something new happens for Igm Monoclonal Gammopathy of Undetermined Significance.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy [Phase 2]
Phase 2 clinical trial update for ACALA-R in predominantly demyelinating IgM-mediated neuropathy; the study involves IgM monoclonal gammopat…